Monetta Financial Services’s Gilead Sciences GILD Stock Holding History

Monetta Financial Services’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13,300	Closed	-$1.85M	–	70
2026 Q1	$1.85M	Hold	13,300	–	–	1.44%	16
2025 Q4	$1.63M	Buy	13,300 +3,300	+33%	+$401K	1.17%	19
2025 Q3	$1.11M	Hold	10,000	–	–	0.78%	39
2025 Q2	$1.11M	Hold	10,000	–	–	0.81%	39
2025 Q1	$1.12M	Hold	10,000	–	–	0.99%	25
2024 Q4	$924K	Hold	10,000	–	–	0.74%	37
2024 Q3	$838K	Buy	+10,000	New	+$763K	0.71%	45
2024 Q1	–	Sell	-10,500	Closed	-$851K	–	53
2023 Q4	$851K	Buy	+10,500	New	+$817K	0.81%	38
2022 Q1	–	Sell	-11,000	Closed	-$799K	–	60
2021 Q4	$799K	Buy	+11,000	New	+$758K	0.62%	35
2016 Q1	–	Sell	-5,000	Closed	-$506K	–	82
2015 Q4	$506K	Hold	5,000	–	–	0.3%	81
2015 Q3	$491K	Buy	+5,000	New	+$555K	0.3%	73
2015 Q1	–	Sell	-10,000	Closed	-$943K	–	97
2014 Q4	$943K	Hold	10,000	–	–	0.49%	49
2014 Q3	$1.06M	Buy	+10,000	New	+$979K	0.56%	48

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Monetta Financial Services's GILD Position: Q2 2026 in Review

Monetta Financial Services sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 13,300 shares — an estimated $1.85M sold.

Monetta Financial Services first reported a position in GILD in Q3 2014 and held it in 13 quarters. The position peaked at $1.85M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Monetta Financial Services reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
Monetta Financial Services sold 13,300 Gilead Sciences shares in Q2 2026, an estimated $1.85M.
Monetta Financial Services first reported a position in Gilead Sciences in Q3 2014 and held it in 13 quarters.
Monetta Financial Services's Gilead Sciences position peaked at $1.85M in Q1 2026.
2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Monetta Financial Services's 13F filing for Q2 2026, filed 10 Aug 2026.